ClosedPublished 22 Mar 2024

Graphite Bio, Inc. /
LENZ Therapeutics Operations, Inc.

Graphite Bio and LENZ Therapeutics complete merger

Buy side: Graphite Bio, Inc.
Buy sideGraphite Bio, Inc.
Target: LENZ Therapeutics Operations, Inc.
TargetLENZ Therapeutics Operations, Inc.
Source · 22 Mar 2024Source-verified
Buy side: Graphite Bio, Inc.
Buy sideGraphite Bio, Inc.
Target: LENZ Therapeutics Operations, Inc.
TargetLENZ Therapeutics Operations, Inc.
01 / BuyerGraphite Bio, Inc.
02 / TargetLENZ Therapeutics Operations, Inc.
Source-verified
01

What happened

Graphite Bio, Inc. and LENZ Therapeutics Operations, Inc. completed their merger on March 21, 2024. The combined company was named LENZ Therapeutics, Inc. and continues to be listed on the Nasdaq.

LENZ Therapeutics Operations, Inc. became a wholly-owned subsidiary of Graphite Bio, Inc. in the merger.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Graphite Bio and LENZ Therapeutics complete merger

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    The source this page is built from.

    Source-verified
  2. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.